Prospective Clinical Evaluation of a Novel Repositionable Plastic Stent for Endosonography-Guided Hepaticogastrostomy With or Without Antegrade Stenting (With Videos) - Report - MDSpire
Advertisement
Clinical Assessment of a New Repositionable Plastic Stent for Endosonography-Guided Hepaticogastrostomy With or Without Antegrade Stenting (Including Videos)
Clinical Assessment of a New Repositionable Plastic Stent for EUS-HGS
Overview
This study evaluates the efficacy and safety of a novel repositionable plastic stent (PS) designed for endosonography-guided hepaticogastrostomy (EUS-HGS) in patients with malignant or benign biliary disease.
Background
Endosonography-guided hepaticogastrostomy (EUS-HGS) is an alternative for managing obstructive jaundice in patients with unresectable malignant biliary obstruction. The development of dedicated stents that enhance the safety and efficacy of EUS-HGS is crucial, particularly given concerns regarding adverse events such as bile leakage and stent migration.
Data Highlights
No numerical data or trial data were provided in the source material.
Key Findings
The repositionable PS delivery system allows for pullback in difficult cases.
The stent design includes features to prevent migration or dislodgement.
Insertion performance of the repositionable PS is comparable to conventional pusher-type PS.
The study was conducted at Tokyo Medical University with a prospective design.
Patients included those with malignant biliary obstruction or benign biliary disease.
Clinical Implications
The repositionable PS may offer a safer and more effective option for EUS-HGS, potentially reducing the risk of complications associated with traditional stents. Clinicians should consider this new technology in appropriate cases of biliary obstruction.
Conclusion
The novel repositionable plastic stent shows promise in enhancing the safety and efficacy of EUS-HGS procedures. Further studies may be warranted to confirm these findings in larger populations.
